drugset / Trial / NCT00543933

Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease

NCT00543933 ↗

Phase 0 Terminated 18 enrolled The Cleveland Clinic
NaSingle-groupOpen-labelTreatment

Summary

Inhaled nitric oxide in patients with pulmonic valve insufficiency.

Timeline

Start
2007-10
Primary completion
2010-06
Completion
2010-06

Outcome

Outcome not reported

Stopped: “Investigator left institution”

Drugs

EvaluationDrugModalityDoseRoute
Subject inhaled nitric oxide Unknown 40 ppm Inhaled